Amino Acid Dysregulation Metabotypes Diagnostics for Autism Spectrum Disorders – INSAR 2018 [PDF]
 /  Posters / Posters & Publications / Amino Acid Dysregulation Metabotypes Diagnostics for Autism Spectrum Disorders – INSAR 2018 [PDF]

Amino Acid Dysregulation Metabotypes Diagnostics for Autism Spectrum Disorders – INSAR 2018 [PDF]

Presented at the International Society for Autism Research (INSAR) Annual Meeting in Rotterdam, Netherlands; May 2018.

NeuroPointDX’s autism clinical study, Children’s Autism Metabolome Project (CAMP), is the largest study to identify changes in metabolism associated with autism spectrum disorder (ASD). Over 1,100 children enrolled in the study at eight clinical sites across the United States. NeuroPointDX developed a test panel for metabolic subtypes (metabotypes) associated with ASD.

Related Posts

(608) 441-8187

504 S. Rosa Rd. Suite 150
Madison, WI 53719

contact@NeuroPointDx.com

FOLLOW US